Zinbryta

2017 KEI asks HHS to use Bayh-Dole rights in Zinbryta patent (drug for multiple sclerosis), September 15, 2017.

Universal Copyright Convention (UCC)

Universal Copyright Convention (UCC) Universal Copyright Convention as revised at Paris on 24 July 1971, with Appendix Declaration relating to Article XVII and Resolution concerning Article XI 1971 Universal Copyright Convention, with Appendix Declaration relating to Articles XVII and Resolution… Continue Reading

KEI asks FTC to block Celgene Acquisition of Juno​ Therapeutics, over BCMA-targeted CAR T treatment for Multiple Myeloma

On February 14, 2018, KEI meet with the FTC to express our opposition to Celgene’s proposed acquisition of Juno Therapeutics. Celgene-Juno-KEI-FTC16Feb2018 The Celgene acquisition of Juno Therapeutics would give Celgene control over competing candidates for the treatment of multiple myeloma… Continue Reading

Colombia

Blogs about compulsory licensing in Colombia are here.

2012-2013-nih-march-in-request-for-ritonavir

Pages on the 2012-2013 NIH Request November 1, 2013. NIH rejects March-In petition, also rejects proposed rules on pricing of and access to government funded inventions. October 15, 2013. 15 frequently asked questions about the 2012 ritonavir March-In petition October… Continue Reading

SCP 26

July 3 to July 6, 2017 WIPO’s Page for the Meeting SCP26 – Agreement reached on future work reached at WIPO Standing Committee on the Law of Patents (6 July 2017) WIPO SCP 26 KEI Side Event: Running royalties as… Continue Reading